Duavive
oestrogens conjugated
bazedoxifene
Postmenopause
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
Conbriza
bazedoxifene
Osteoporosis, Postmenopausal
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
APPM Respipharm - referral
formaldehyde-inactivated whole-cell bacterial vaccine containing three strains of Actinobacillus pleuropneumoniae (serotypes 2, 9 and 11) and one strain of Pasteurella multocida (serotype A)
Article 33
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralVeterinary
EMEA-000998-PIP01-10 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/155/2010
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Brilence
bazedoxifene
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application